GLP-1 giant Eli Lilly has once again taken to the medium of short film to deliver an important message about obesity. In early 2024, the Big Pharma debuted a pair of unbranded shorts entitled “Big ...
Please provide your email address to receive an email when new articles are posted on . There is an “unbelievable number of anti-obesity drugs in development,” including GLP-1 receptor agonists with ...
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Obesity can lead to a host of other medical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results